Description of the medicine: Gidazepam (Gidazepamum)
GIDAZEPAM (Gidazepamum). 7-Bromo-1- (hydrazinocarbonyl) methyl-5-phenyl-1, 2-dihydro-ZN-1, 4-benzodiazepin-2-one.
Fine crystalline powder, white or white with a slightly creamy tint. It is practically insoluble in water, slightly soluble in alcohol.
A tranquilizer that has anxiolytic and anticonvulsant effects. It differs from other benzodiazepine (and non-benzodiazepine) tranquilizers by the presence of an activating effect, a mild muscle relaxant effect.
Gidazepam is prescribed to adults as a “daytime” tranquilizer for neurotic, neurosis-like, psychopathic and psychopathic asthenia, migraine, in conditions accompanied by anxiety, fear, increased irritability, tension, obsessiveness, sleep disturbances, as well as emotional lability, to relieve withdrawal symptoms alcoholism and maintenance therapy during remission for patients with chronic alcoholism.
Assign inside by 0.02 - 0.05 g 3 times a day, gradually increasing the dose. The average daily dose in the treatment of patients with neurotic, neurosis-like, psychopathic, psycho-like conditions is 0.06 - 0.2 g, with migraine and logoneurosis - 0.04 - 0.6 g.
When stopping alcohol withdrawal symptoms, the initial dose is 0.05 g, the average daily dose is 0.15 g. The highest daily dose for these conditions is 0.5 g. During remission, gidazepam is used as a supportive therapy for the development of neurotic conditions in an average daily dose. 0.05 - 0.15 g.
The duration of treatment with gidazepam is determined by the patient's condition and tolerance to the drug and ranges from several days to 3 to 4 months.
Possible side effects and contraindications are the same as for other benzodiazepine tranquilizers.
Release form: tablets on 0,02 and 0,05 g (20 and 50 mg).
Storage: List B. In a dry, dark place.